Intern, Biostatistics

Revolution Medicines•Redwood City, CA

4d•$67,000 - $81,000•Hybrid

About The Position

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Biostatistics summer intern will work for 8-12 weeks under the supervision of experienced Biostatisticians on theoretical or applied problems with direct relevance to on-going clinical drug development research in Oncology. During the internship, the student is expected to implement methodological developments using SAS/R and conduct simulation studies as needed. At the end of the internship, the student is expected to give a department-wide presentation on their research topic and prepare a final written report.

Requirements

Must have strong programming skills in SAS or R.
Must have a solid background on survival analysis.
Demonstrated problem-solving ability and strong oral and written communication skills.
Enrollment in a full-time graduate program and have completed at least two full years of graduate course work prior to the start of the internship.

Nice To Haves

Familiarity with advanced statistical methods, including casual inference, Bayesian statistics, covariate-adjusted modeling.
Experiencee with simulation-based methods and predictive modeling to support the clinical development decision.